Juhn S K, Rybak L P, Prado S
Ann Otol Rhinol Laryngol. 1981 Mar-Apr;90(2 Pt 1):135-41. doi: 10.1177/000348948109000208.
The blood-labyrinth barrier is concept that has evolved based on marked difference in chemical composition between perilymph and blood. Studies reported here have been designed to manipulate physiologic, metabolic, and pharmacologic conditions in experimental animals in order to determine the characteristics of this regulatory mechanisms. Tracer studies of uptake of sodium, calcium, and albumin from blood into perilymph showed that these substances penetrate into inner ear fluids quite slowly. Injections of ototoxic substances (kanamycin, furosemide) show limited transport of these agents into perilymph. Administration of an osmotic agent (urea) resulted in a parallel but delayed elevation of perilymph concentration. The possible role of a alteration of blood-labyrinth barrier in inner ear disorders has been discussed.
血迷路屏障是一个基于外淋巴和血液之间化学成分显著差异而演变出的概念。此处报道的研究旨在操控实验动物的生理、代谢和药理状况,以确定这种调节机制的特征。对从血液到外淋巴中钠、钙和白蛋白摄取的示踪研究表明,这些物质进入内耳液的速度相当缓慢。注射耳毒性物质(卡那霉素、呋塞米)显示这些药物进入外淋巴的转运有限。给予渗透剂(尿素)导致外淋巴浓度平行但延迟升高。已经讨论了血迷路屏障改变在内耳疾病中的可能作用。